Abstract
The impact of salivary flow reduction following medication (scopolamine and botulinum neurotoxin) on social interaction and emotional development (self-esteem) was evaluated in a group of 45 children with cerebral palsy who suffered from severe drooling. The children ranged in age from 3 to 16 years (median 9.1 years); 28 were male, 17 female. A questionnaire to document the impact of drooling on social interaction and self-esteem for both the children and their parents was developed and administered during the use of scopolamine and up to 24 weeks after intraglandular botulinum neurotoxin in the submandibular glands. The reduction of drooling was related to increased social contacts with peers. In addition, parents perceived that the impact of drooling on the level of the child’s satisfaction on physical appearance, relations within the extended family, and life in general increased. Although medication led to (temporary) positive changes, many social and emotional consequences remained unchanged. Conclusion: Interventions to treat drooling should not only be evaluated using measurements of drooling, but the consequences on social interaction and self-esteem should also be assessed.
Similar content being viewed by others
Abbreviations
- BoNT :
-
botulinum neurotoxin
- CP :
-
cerebral palsy
- DA :
-
developmental age
- VAS :
-
visual analogue scale
References
Bachrach SJ, Walter RS, Trzcinski K (1998) Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr (Phila) 37: 485–490
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP (1989) Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 31: 309–319
Cruickshank WM (1952) A study of the relation of physical disability to social adjustment. Am J Occupat Ther 6: 100–109
Ekedahl C, Hallen O (1973) Quantitative measurement of drooling. Acta Otolaryngol 75: 464–469
Finkelstein DM, Crysdale WS (1992) Evaluation and management of the drooling patient. J Otolaryngol 21: 414–418
Jongerius PH, Rotteveel JJ, Van den Hoogen F, Joosten F, Van Hulst K, Gabreels FJM (2001) Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 160: 509–512
Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreels FJ, van Hulst K, Rotteveel JJ (2004) Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 114: 620–627
Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreels FJ, van Hulst K, van den Hoogen FJ (2004) Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63:1371–1375
Landgraf JM, Abetz L, Ware JE (1996) Child Health Questionnaire (CHQ): a user’s manual. The Health Institute, Boston
Minde KK (1978) Coping styles of 24 adolescents with cerebral palsy. Am J Psychiatry 135: 1344–1349
Rapp D (1980) Drool control: long-term follow-up. Dev Med Child Neurol 22: 448–453
Tahmassebi JF, Curzon MEJ (2003) Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol 45: 613–617
Teplin SW, Howard JA, O’Connor MJ (1981) Self-concept of young children with cerebral palsy. Dev Med Child Neurol 23: 730–738
Van De Heyning PH, Marquet JF, Creten WL (1980) Drooling in children with cerebral palsy. Acta Otorhinolaryngol Belg 34: 691–705
Acknowledgements
This work was supported by a grant from the ‘Johanna KinderFonds’, a fund-raising organisation for child rehabilitation in The Netherlands. The authors also express their gratitude to Ricky van der Heijden, trial monitor, for her professional support during this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van der Burg, J.J.W., Jongerius, P.H., van Limbeek, J. et al. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr 165, 37–41 (2006). https://doi.org/10.1007/s00431-005-1759-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-1759-z